×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
Providence Medical Technology Announces First Commercial Cases Using Its Next-Generation, 3D-Printed CORUS™ Posterior Cervical Stabilization System (PCSS 3D-T)
StimCardio Closes an Oversubscribed $30 Million Series A Financing to Advance Its Wearable Therapeutic for Atrial Fibrillation
Carterra Integrates Its Vega™ System with Grenova Robotics’ KX2 Collaborative Robot to Create an Automated HT-SPR Work Cell
New HFSA Scientific Statement Calls for Recognition of Right Heart Failure as a Distinct Clinical Syndrome
Blue Arbor Technologies Raises $10.5 Million Series A Led by Ottobock
Mabtech Joins the Encompass Preferred Procurement Program at Fisher Scientific
Vantive Announces Expansion of HomeAdvantage and Highlights New Evidence to Advance Home Dialysis During Kidney Week
GrOwnValve Achieves Primary Safety Endpoint in First-in-Human Heart Valve Study
RYBREVANT®▼ (amivantamab), administered subcutaneously, demonstrates a 77% overall response rate in the first-line treatment of patients with certain types of advanced head and neck cancer
KFSH Brings Specialized Follow-Up Care Closer to Patients by Expanding Virtual Care Pathways
KFSH Enhances Emergency Access by Integrating Virtual Care and Specialist Coordination
Swanson Vitamins Named Official Supplements Provider of the United States Hockey League
ZERO Prostate Cancer responds to the devastating 57% cut in lifesaving medical research programs
By
Zero Prostate Cancer
Zero Prostate Cancer
11 Mar 2025
Hologic partners with the CDC to develop H5N1 bird flu testing
8 Top Secret Toe Problem Fixes Most Recommended by Podiatrists to Relieve Pain
Syra Health Announces Positive Preliminary Results from Syrenity Study Led by Indiana University
Now Available in Canada: Lenire Tinnitus Treatment Device
At-Home Genetic Testing Kits Launch by Shed to Unlock Personalized Wellness Insights
Featured Press Releases
Providence Medical Technology Announces First Commercial Cases Using Its Next-Generation, 3D-Printed CORUS™ Posterior Cervical Stabilization System (PCSS 3D-T)
StimCardio Closes an Oversubscribed $30 Million Series A Financing to Advance Its Wearable Therapeutic for Atrial Fibrillation
29 Oct 2026
StimCardio, a clinical-stage medical device company developing non-invasive wearable therapeutics
...
Carterra Integrates Its Vega™ System with Grenova Robotics’ KX2 Collaborative Robot to Create an Automated HT-SPR Work Cell
New HFSA Scientific Statement Calls for Recognition of Right Heart Failure as a Distinct Clinical Syndrome
Blue Arbor Technologies Raises $10.5 Million Series A Led by Ottobock
Mabtech Joins the Encompass Preferred Procurement Program at Fisher Scientific
Providence Medical Technology Announces First Commercial Cases Using Its Next-Generation, 3D-Printed CORUS™ Posterior Cervical Stabilization System (PCSS 3D-T)
By
Providence Medical Technology, Inc.
Providence Medical Technology, Inc.
29 Oct 2026
StimCardio Closes an Oversubscribed $30 Million Series A Financing to Advance Its Wearable Therapeutic for Atrial Fibrillation
By
StimCardio Medical
StimCardio Medical
29 Oct 2026
Carterra Integrates Its Vega™ System with Grenova Robotics’ KX2 Collaborative Robot to Create an Automated HT-SPR Work Cell
By
Grenova Robotics
Grenova Robotics
28 Oct 2026
New HFSA Scientific Statement Calls for Recognition of Right Heart Failure as a Distinct Clinical Syndrome
By
Heart Failure Society of America
Heart Failure Society of America
28 Oct 2026
Blue Arbor Technologies Raises $10.5 Million Series A Led by Ottobock
By
Blue Arbor Technologies
Blue Arbor Technologies
28 Oct 2026
Mabtech Joins the Encompass Preferred Procurement Program at Fisher Scientific
By
Mabtech
Mabtech
27 Oct 2026
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Most Popular
Nature Publication Highlights the Benefits of Tropis® Intradermal
By
PharmaJet
Apr 24
Selected by CMS (Centers for Medicare & Medicaid Services), Essen Health Care to Test Medicare Dementia Care Model
By
Essen Health Care
Jan 28
Akebia's Vafseo® (vadadustat) Tablets FDA Approved for Anemia Treatment in Dialysis Patients
By
Akebia Therapeutics, Inc.
Mar 28
October
2026
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe to Our Monthly Newsletter
Subscribe to Healthcare Era’s monthly newsletter,
Healthcare Leaders Digest
®, to receive timely updates from across the healthcare industry.
I agree with the
Terms and conditions
×
and the
Privacy policy
×
Please enable the javascript to submit this form
Subscribe
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. To find out more, please click
here
.
I understand